Combination of MLo-1508 with sunitinib for the experimental treatment of papillary renal cell carcinoma.
Renal cell carcinoma (RCC) is the 14th most incident cancer worldwide, and no curative therapeutic options are available for advanced and metastatic disease. Hence, new treatment alternatives are urgently needed to tackle disease management and drug …